Ken Mariash, Sinaptica Therapeutics - Spotlight Studio | LSI Europe '23

Sinaptica Therapeutics is a clinical-stage company that is developing a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Ken Mariash
Ken Mariash
CEO, Sinaptica Therapeutics